Everads Injector Shows Strong Results in Retinal Study
Tel Aviv, Israel | May 3, 2026 Everads Therapy has announced the publication of first-in-human clinical data for its...
clinical trial
Advertisement
Contineum Therapeutics Reports Positive PIPE-791 Data
SAN DIEGO, April 30, 2026 Contineum Therapeutics, Inc. announced positive topline results from its Phase 1b clinical trial of...
Corcept Therapeutics Reports ALS Survival Breakthrough
REDWOOD CITY, California, April 30, 2026 Corcept Therapeutics Incorporated announced compelling two-year overall survival data from its Phase 2...
MRM Health Launches Phase 2b UC Trial with MH002
GHENT, Belgium, May 2, 2026 MRM Health announced the initiation of its Phase 2b STARFISH-UC clinical trial (NCT07296315) evaluating...
AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer
WASHINGTON, D.C., April 30, 2026 AstraZeneca announced that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC)...
Advertisements
Bambusa Therapeutics Completes BBT001 Trial Enrollment
BOSTON, MASSACHUSETTS, April 30, 2026 Bambusa Therapeutics has announced the successful completion of patient enrollment in its Phase 1b/2a...
EnGeneIC Doses First Patient in GBM EDV Therapy Trial
SYDNEY, AUSTRALIA, May 01, 2026 EnGeneIC has announced a critical clinical milestone with the first patient dosed in its...
Laguna Gains FDA IND Clearance for LGNA-100 Therapy
SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
InnoCare Advances Phase III Orelabrutinib Trial for SLE
BEIJING, April 29, 2026 InnoCare Pharma has announced that the first patient has been dosed in the registrational Phase...
Advertisement
